FORT Joins Novikombank Development Program

FORT, a Nacimbio Holding biopharmaceutical company, has joined the Novikombank Development Program created to reward the best employees. Those who achieved significant results in their job will be granted special service conditions at the base bank of the Rostec State Corporation. The corresponding agreement was signed within the framework of the business program at the 9th ARMY 2023 International Military and Technical Forum.

The agreement was signed by Alexey Kuznetsov, Deputy Chairman of the Board of Novikombank, and Pavel Sidorenkov, Deputy General Manager for Economics and Finance of Nacimbio.

The Development Program was introduced by Novikombank jointly with the Rostec State Corporation to attract and retain highly qualified young specialists in the real sector of the economy by increasing the motivation of the best employees at the enterprises.

Banking products and services on preferential terms will now be available to company employees who have distinguished themselves in production or social activities, as well as those who received awards from the company. Participants in the Development Program have access to preferential mortgage rates and loans for education, or other purposes. Among the employees who may qualify for special conditions are winners of corporate awards and production competitions, employees with labor awards and incentives, highly competent young specialists, as well as combatants and employees performing tasks related to military operations.

“Russia bets on achieving technological sovereignty, and, thus, on young engineers. They are the ones who are capable of becoming valuable personnel elite, creating the country’s scientific and production progress for the coming decades. Novikombank has long been focused on advances and development of financial incentive products for industrial employees, motivating their professional development and competencies. They are the basis for strengthening the significant potential of key sectors of the domestic economy,” noted Elena Georgieva, Chairman of the Board of Novikombank, curator of Voronezh SoyuzMash of Russia.

FORT is a state-of-the-art biotech company based in the Ryazan Region. The plant has a well-developed infrastructure ensuring upstream and downstream processes compliant with the international Good Manufacturing Practice (GMP). Being Russia’s largest manufacturer of influenza vaccines, the company annually release more than 30 million doses of products.